About Selexipag
Class: | Pulmonary vasodilator, specifically a selective prostacyclin receptor agonist
Use: | Treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and delay clinical worsening
Adult dose: | Initiate at 200 mcg twice daily; may be titrated to a maximum of 1600 mcg twice daily based on tolerability and clinical response
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in children
Side effects: | Headache, diarrh
Drug Class
Pulmonary vasodilator, specifically a selective prostacyclin receptor agonist
Uses & Indications
Treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and delay clinical worsening
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: Actelion Pharmaceuticals Ltd., SWITZERLAND
Package Size
60s
Price & Supplier
Price in UAE: AED 25515.50
Dosage Information
Adult Dose
Initiate at 200 mcg twice daily; may be titrated to a maximum of 1600 mcg twice daily based on tolerability and clinical response
Pediatric Dose
Safety and efficacy not established in pediatric patients; not recommended for use in children
Side Effects
Headache, diarrhea, nausea, jaw pain, flushing, and abdominal pain
Contraindications & Precautions
Severe hepatic impairment (Child-Pugh class C), hypersensitivity to selexipag or any component of the formulation
Important Warnings
Risk of bleeding, especially in patients with underlying bleeding disorders; caution in patients with hepatic impairment; may cause hypotension; monitor for signs of pulmonary edema and worsening PAH symptoms
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.